Chest pain is notoriously complex, presenting with a wide spectrum of symptoms that often overlap across organ systems. Medical professionals frequently face the diagnostic challenge of differentiating between cardiac ischemia, respiratory pathologies, and gastrointestinal disorders. While conditions like Gastroesophageal Reflux Disease (GERD) and musculoskeletal strains can mimic acute coronary syndromes, they stem from entirely unrelated causes. However, more often than not, patients also experience tightness and squeezing pain in their chest, signalling the presence of cardiac pain or angina, which may indicate underlying issues such as coronary artery disease and so on. Prompt and accurate diagnosis of these presentations is critical to ensure patient safety, prevent unnecessary interventions, and direct individuals toward the appropriate clinical pathway. Clinical Indicators of Gastrointestinal Origin Dietary habits and digestive function heavily influence gastrointes...

 Heart blockages occur when the arteries carrying blood to the heart start narrowing. The heart receives less oxygen than what is required. In the early stages, this reduced supply is mild and inconsistent, which is why symptoms can be inconsistent and hard to pinpoint. Do consult a doctor if you are experiencing the following symptoms: 1.       Fatigue 2.       Shortness of breath during activities that have not seemed difficult before. 3.       Pressure in the middle of the chest. In a landmark trial conducted by the researchers from NYU Grossman School of Medicine and Stanford University, they present some important findings related to heart blockages and their treatment. Background of the ISCHEMIA study Funded by the National Heart, Lung, and Blood Institute, the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial studied patients with...

  What the Landmark ORBITA Trial Means for Patients, Cardiologists and the Future of Heart  Disease Management A Landmark Study That Sent Shockwaves Through Cardiology On 2 November 2017, The Lancet, one of the world's most prestigious medical journals, published a landmark clinical trial that has challenged one of the most deeply held beliefs in modern cardiology. The study, known as ORBITA (Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina), has generated intense debate among cardiologists across the world and may ultimately reshape the management of patients with stable coronary artery disease. For nearly four decades, angioplasty has been considered the preferred treatment for relieving chest pain in patients with stable angina. Although previous clinical trials had already demonstrated that angioplasty does not reduce the risk of future heart attacks or improve survival in stable patients, many physicians continued to ...

EECP in 2026: What the Latest Clinical Research Tells Us Enhanced External Counterpulsation, widely known as EECP treatment, is gaining fresh clinical validation in 2026. A new study published in Frontiers in Cardiovascular Medicine has strengthened the evidence base for this non-invasive cardiac care option. Heal Your Heart, one of India's reputed EECP treatment centers, has closely followed this research. It reflects a growing global recognition of EECP therapy as an effective tool in cardiac rehabilitation. Led by Dr. S. Ramasamy, an internationally renowned non-invasive cardiac care expert, Heal Your Heart was founded with a clear vision. That vision was to offer patients a scientifically backed, drug-free, surgery-free path to cardiovascular health. Dr. Ramasamy's decades of specialization in EECP therapy have positioned the center as a trusted name in evidence-based cardiac care. What the 2026 Study Found The February 2026 study followed 798 patients with acute ...

  Tamil Nadu’s cardiovascular mortality share rose from 21% of all deaths in 1990 to 36% in 2016, placing the state among the top three in India for cardiovascular disease (CVD) mortality. Ischaemic heart disease now accounts for the single largest share of years of life lost to premature death in the state. Overall mortality patterns across Tamil Nadu have remained relatively steady over the past decade, but this stability conceals an uncomfortable reality: heart disease continues to claim a growing and disproportionate share of that fixed number. Non-communicable diseases are responsible for more than 75% of all deaths in the state, and hypertension alone contributes to nearly 22% of them. The figures point to a population ageing into risk faster than its healthcare-seeking behaviour is adapting. Reading between these numbers reveals what they do not state directly: cardiovascular disease in Tamil Nadu is not an emerging threat. It is an established one, and the gap lies in e...